Zero x-ray cardiac resynchronization therapy device implantation guided by a nonfluoroscopic mapping system: A pilot study

Colella, Andrea; Giaccardi, Marzia; Colella, Tommaso; Modesti, Pietro Amedeo

doi:10.1016/j.hrthm.2016.03.021

Cited by 30 publications

(39 citation statements)

References 35 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Several studies utilized three‐dimensional mapping systems for CIED implantation. In those studies, no acute or long‐term adverse effects on the pulse generator were described …”

Section: Discussionmentioning

confidence: 99%

Long‐term efficacy and safety of radiofrequency catheter ablation of atrial fibrillation in patients with cardiac implantable electronic devices and transvenous leads

Dinshaw¹,

Schäffer²,

Akbulak³

et al. 2019

Cardiovasc electrophysiol

View full text Add to dashboard Cite

Introduction Long‐term efficacy and safety are uncertain in patients with cardiac implantable electronic devices (CIED) and transvenous leads (TVL) undergoing radiofrequency catheter ablation of atrial fibrillation (AF). Thus, we assessed the outcome of AF ablation in those patients during long‐term follow‐up using continuous atrial rhythm monitoring (CARM). Methods and Results A total of 190 patients (71.3 ± 10.7 years; 108 (56.8% men) were included in this study. At index procedure 81 (42.6%) patients presented with paroxysmal AF and 109 (57.4%) with persistent AF. The ablation strategy included pulmonary vein isolation in all patients and biatrial ablation of complex fractionated electrograms with additional ablation lines, if appropriate. AF recurrences were assessed by CARM‐ and CIED‐related complications by device follow‐up. After a mean follow‐up of 55.4 ± 38.1 months, freedom of AF was found in 86 (61.4%) and clinical success defined as an AF burden less than or equal to 1% in 101 (72.1%) patients. Freedom of AF was reported in 74.6% and 51.9% (P = 0.006) and clinical success in 89.8% and 59.3% (P < 0.001) of patients with paroxysmal and persistent AF, respectively. In 3 of 408 (0.7%) ablation procedures, a TVL malfunction occurred within 90 days after catheter ablation. During long‐term follow‐up 9 (4.7%) patients showed lead dislodgement, 2 (1.1%) lead fracture, and 2 (1.1%) lead insulation defect not related to the ablation procedure. Conclusion Our findings using CARM demonstrate long‐term efficacy and safety of radiofrequency catheter ablation of AF in patients with CIED and TVL.

show abstract

“…Several studies utilized three‐dimensional mapping systems for CIED implantation. In those studies, no acute or long‐term adverse effects on the pulse generator were described …”

Section: Discussionmentioning

confidence: 99%

Long‐term efficacy and safety of radiofrequency catheter ablation of atrial fibrillation in patients with cardiac implantable electronic devices and transvenous leads

Dinshaw¹,

Schäffer²,

Akbulak³

et al. 2019

Cardiovasc electrophysiol

View full text Add to dashboard Cite

show abstract

“…In the setting of device implantations, EAMS have been used to reduce radiation dose particularly in children and pregnant women . Recently, the first experiences of CRT devices implantation guided by EAMS have been published . The preliminary findings of these studies indicated that this approach significantly reduces radiation exposure and may even allow fluoroscopy to be completely avoided .…”

Section: Discussionmentioning

confidence: 99%

Three‐Dimensional Electroanatomic Mapping System‐Enhanced Cardiac Resynchronization Therapy Device Implantation: Results From a Multicenter Registry

Greco

Maines

Marini

et al. 2016

Cardiovasc electrophysiol

Self Cite

View full text Add to dashboard Cite

show abstract

“…Novel three‐dimensional (3D) mapping systems, such as Ensite NavX (St. Jude Medical, St. Paul, MN, USA), CARTO (Biosense Webster, Diamond Bar, CA, USA), and LocaLisa (Medtronic, Minneapolis, MN, USA), have been developed and implemented in electrophysiological procedure to guide the navigation of catheters inside the heart and to reduce radiation exposure . However, to date there have been few reports on the use of 3D mapping systems for the implantation of cardiac pacemakers, only described in single case reports or in case series for reducing radiation exposure . Recently, Colella et al.…”

Section: Introductionmentioning

confidence: 99%

Zero‐fluoroscopy permanent pacemaker implantation using Ensite NavX system: Clinical viability or fanciful technique?

Guo

Qiu

Wang

et al. 2018

Pacing Clinical Electrophis

View full text Add to dashboard Cite

show abstract

Zero x-ray cardiac resynchronization therapy device implantation guided by a nonfluoroscopic mapping system: A pilot study

Cited by 30 publications

References 35 publications

Long‐term efficacy and safety of radiofrequency catheter ablation of atrial fibrillation in patients with cardiac implantable electronic devices and transvenous leads

Long‐term efficacy and safety of radiofrequency catheter ablation of atrial fibrillation in patients with cardiac implantable electronic devices and transvenous leads

Three‐Dimensional Electroanatomic Mapping System‐Enhanced Cardiac Resynchronization Therapy Device Implantation: Results From a Multicenter Registry

Zero‐fluoroscopy permanent pacemaker implantation using Ensite NavX system: Clinical viability or fanciful technique?

Contact Info

Product

Resources

About